Lozada, Reynaldo T.
HRN: 11-63-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/26/2025
12/02/2025
IV
300mg
Q 6 Hrs
Decubitus Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes